Evidence map›Paper›PMID 26320741›Full record

ArticleCellular & molecular immunology2016

The IRAK-ERK-p67phox-Nox-2 axis mediates TLR4, 2-induced ROS production for IL-1β transcription and processing in monocytes.

Ankita Singh, Vishal Singh, Rajiv L Tiwari, Tulika Chandra, Ashutosh Kumar, Madhu Dikshit, Manoj K Barthwal

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Cellular & molecular immunology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 61 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Raspberry polyphenols target molecular pathways of heart failure.The Journal of nutritional biochemistry · 2024
    Article
  8. Article
  9. Review
  10. Article
  11. Antioxidants (Basel, Switzerland) · 2022
    Article
  12. ERK1/2 in immune signalling.Biochemical Society transactions · 2022
    Review
  13. Prophylactic treatment ofFrontiers in immunology · 2022
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Ankita SinghPharmacology Division, CSIR-Central Drug Research Institute, B.S. 10/1, Sector 10, Sitapur Road, Jankipuram Extension, Lucknow 226031, Uttar Pradesh, India.
Vishal SinghPharmacology Division, CSIR-Central Drug Research Institute, B.S. 10/1, Sector 10, Sitapur Road, Jankipuram Extension, Lucknow 226031, Uttar Pradesh, India.
Rajiv L TiwariPharmacology Division, CSIR-Central Drug Research Institute, B.S. 10/1, Sector 10, Sitapur Road, Jankipuram Extension, Lucknow 226031, Uttar Pradesh, India.
Tulika ChandraDepartment of Transfusion Medicine and Blood Bank, King George's Medical University, Lucknow, Uttar Pradesh, India.
Ashutosh KumarDepartment of Pathology, King George's Medical University, Lucknow, Uttar Pradesh, India.
Madhu DikshitPharmacology Division, CSIR-Central Drug Research Institute, B.S. 10/1, Sector 10, Sitapur Road, Jankipuram Extension, Lucknow 226031, Uttar Pradesh, India.
Manoj K BarthwalPharmacology Division, CSIR-Central Drug Research Institute, B.S. 10/1, Sector 10, Sitapur Road, Jankipuram Extension, Lucknow 226031, Uttar Pradesh, India.
Central Drug Research Institute · INKing George's Medical University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In monocytic cells, Toll-like receptor 4 (TLR4)- and TLR2-induced reactive oxygen species (ROS) cause oxidative stress and inflammatory response; however, the mechanism is not well understood. The present study investigated the role of interleukin-1 receptor-associated kinase (IRAK), extracellular signal-regulated kinase (ERK), p67phox and Nox-2 in TLR4- and TLR2-induced ROS generation during interleukin-1 beta (IL-1β) transcription, processing, and secretion. An IRAK1/4 inhibitor, U0126, PD98059, an NADPH oxidase inhibitor (diphenyleneiodonium (DPI)), and a free radical scavenger (N-acetyl cysteine (NAC))-attenuated TLR4 (lipopolysaccharide (LPS))- and TLR2 (Pam3csk4)-induced ROS generation and IL-1β production in THP-1 and primary human monocytes. An IRAK1/4 inhibitor and siRNA-attenuated LPS- and Pam3csk4-induced ERK-IRAK1 association and ERK phosphorylation and activity. LPS and Pam3csk4 also induced IRAK1/4-, ERK- and ROS-dependent activation of activator protein-1 (AP-1), IL-1β transcription, and IL-1β processing because significant inhibition in AP-1 activity, IL-1β transcription, Pro- and mature IL-β expression, and caspase-1 activity was observed with PD98059, U0126, DPI, NAC, an IRAK1/4 inhibitor, tanshinone IIa, and IRAK1 siRNA treatment. IRAK-dependent ERK-p67phox interaction, p67phox translocation, and p67phox-Nox-2 interaction were observed. Nox-2 siRNA significantly reduced secreted IL-1β, IL-1β transcript, pro- and mature IL-1β expression, and caspase-1 activity indicating a role for Nox-2 in LPS- and Pam3csk4-induced IL-1β production, transcription, and processing. In the present study, we demonstrate that the TLR4- and TLR2-induced IRAK-ERK pathway cross-talks with p67phox-Nox-2 for ROS generation, thus regulating IL-1β transcription and processing in monocytic cells.

Indexed as

Transcription, GeneticCell LineExtracellular Signal-Regulated MAP KinasesHumansInterleukin-1betaInterleukin-1 Receptor-Associated KinasesLipopeptidesLipopolysaccharidesMembrane GlycoproteinsMonocytesNADPH Oxidase 2NADPH OxidasesPhosphoproteinsReactive Oxygen SpeciesSignal TransductionToll-Like Receptor 2CYBB protein, humanExtracellular Signal-Regulated MAP KinasesInterleukin-1betaInterleukin-1 Receptor-Associated KinasesIRAK1 protein, humanLipopeptidesLipopolysaccharidesMembrane GlycoproteinsNADPH Oxidase 2NADPH Oxidasesneutrophil cytosol factor 67KPam(3)CSK(4) peptidePhosphoproteinsReactive Oxygen SpeciesToll-Like Receptor 2Toll-Like Receptor 4Transcription Factor AP-1

Identifiers

PMID26320741
PMCPMC5101443
OpenAlexW2343739444

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.